Suppr超能文献

比较 ST 段抬高型急性心肌梗死患者经直接经皮冠状动脉介入治疗后伴和不伴非梗死相关冠状动脉慢性完全闭塞患者的 5 年结局。

Comparison of five-year outcomes of patients with and without chronic total occlusion of noninfarct coronary artery after primary coronary intervention for ST-segment elevation acute myocardial infarction.

机构信息

Third Department of Cardiology, Silesian Centre for Heart Diseases, Medical University of Silesia, Zabrze, Poland.

出版信息

Am J Cardiol. 2012 Jan 15;109(2):208-13. doi: 10.1016/j.amjcard.2011.08.026. Epub 2011 Oct 12.

Abstract

The aim of the present study was to evaluate the effect of concurrent chronic total occlusion (CTO) in a noninfarct-related artery (IRA) on the long-term prognosis in patients with ST-segment elevation myocardial infarction and multivessel coronary disease. Of 1,658 consecutive patients with ST-segment elevation myocardial infarction, 666 with multivessel coronary disease who underwent percutaneous coronary intervention from 1999 to 2004 were included in the present analysis. The patients were divided into 2 groups: no CTO and CTO. The first group included 462 patients without CTO (69%) and the second group included 204 patients with CTO in a non-IRA (31%). The in-hospital mortality rate was 6.3% and 21.1% (p < 0.0001) and the 5-year mortality rate was 22.5% and 40.2% (p < 0.0001) for the no-CTO and CTO patients, respectively. Multivariate analysis revealed that after correction for baseline differences CTO in a non-IRA was a strong, independent predictor of 5-year mortality in patients undergoing percutaneous coronary intervention (hazard ratio 1.85; 95% confidence interval 1.35 to 2.53; p = 0.0001). In conclusion, the presence of CTO in a non-IRA in patients with ST-segment elevation myocardial infarction and multivessel coronary disease is a strong and independent risk factor for greater 5-year mortality.

摘要

本研究旨在评估非梗死相关动脉(IRA)中同时存在慢性完全闭塞(CTO)对伴有多支血管病变的 ST 段抬高型心肌梗死(STEMI)患者长期预后的影响。在 1658 例连续的 STEMI 患者中,纳入了 1999 年至 2004 年间接受经皮冠状动脉介入治疗的 666 例多支血管病变患者进行本分析。患者被分为 2 组:无 CTO 和 CTO。第一组包括 462 例无 CTO(69%)患者,第二组包括 204 例 IRA 外 CTO(31%)患者。住院死亡率分别为 6.3%和 21.1%(p<0.0001),5 年死亡率分别为 22.5%和 40.2%(p<0.0001)。多变量分析显示,校正基线差异后,IRA 外 CTO 是经皮冠状动脉介入治疗患者 5 年死亡率的一个强独立预测因素(危险比 1.85;95%置信区间 1.35 至 2.53;p=0.0001)。总之,STEMI 合并多支血管病变患者 IRA 外 CTO 的存在是 5 年死亡率更高的一个强而独立的危险因素。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验